Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the safety of the SECURIDRAP4 SELFIA4 bedding system in adults with disorientation, cognitive impairment, or behavior disorders. This interventional, multicenter, prospective, and non-comparative clinical investigation takes place in nursing homes and hospitals in France. It was initiated following the market withdrawal of the first version of the product and is conducted to confirm the safety of the second version as recommended by the ASNM. Participants will use the SECURIDRAP4 SELFIA4 restraint system for 15 consecutive nights as part of their usual care. An independent assessor will monitor the proper use of the bedding system during this period to ensure compliance with safety conditions. The study focuses on adverse events linked to the product, user errors, patient bedridden status, healthcare team satisfaction, and the learning curve for proper use. During the 15-night follow-up, patients will be closely observed, and data on adverse events and user-related safety issues will be collected. Healthcare teams will provide feedback on time savings, comfort, well-being, and respect for patient dignity. The study tracks the rate of patients remaining bedridden each night and monitors the staffs ability to learn the proper use of the SECURIDRAP4 SELFIA4 system. The total participation duration is 15 nights with minimal risks and constraints.
Actively Recruiting
People with mental disorders tend to smoke more than the general population, which contributes to a significant reduction in their life expectancy, mainly due to cardiovascular and respiratory diseases like bronchial cancers. Smoking cessation efforts targeting this group, especially in psychiatric care, are often insufficient. This study evaluates a new intervention called Tabapsy, designed in collaboration with mental health users, professionals, and general practitioners, aimed at helping adults receiving outpatient psychiatric care reduce or quit smoking. The Tabapsy intervention includes a campaign promoting smoking cessation within psychiatric medical psychological centers CMPs and a structured program to support quitting. This program involves a general information meeting to encourage motivation, an assessment workshop to personalize cessation plans based on nicotine dependence, five thematic workshops addressing treatments, emotional management, weight gain, physical activities, and manual occupations, plus peer support groups to foster mutual aid. A facilitator leads these workshops, and a website complements the resources provided. The trial compares this intervention against usual smoking cessation practices in randomized psychiatric sectors. Participants who regularly smoke and agree to join will complete questionnaires at the start, 3 months, and 6 months, assessing tobacco use, dependence, motivation, well-being, knowledge, and satisfaction. The study will measure short-term smoking cessation at 3 months as the primary outcome, along with various secondary outcomes including motivation, quit attempts, mental and physical well-being, cost-effectiveness, and implementation success. The trial plans to include 6,250 participants over 12 months and will combine quantitative and qualitative evaluations.